Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelangelo Luciani

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
SN Comprehensive Clinical Medicine|December 2, 2020
Headache as a Prognostic Factor for COVID-19. Time to Re-evaluatePaolo Martelletti, Enrico Bentivegna, Michelangelo Luciani, et al.
Expert Opinion on Drug Safety|March 22, 2021
Deprescribing in migrainePaolo Martelletti, Michelangelo Luciani, Valerio Spuntarelli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 1, 2022
Reply letter to: Correspondence on 'Coronavirus disease 2019 in patients with cardiovascular disease' (J Cardiovasc Med (Hagerstown). 2022 Jan 1;23(1):e42. doi: 10.2459/JCM.0000000000001276. PMID: 34874340.)Luca Arcari, Michelangelo Luciani, Luca Cacciotti, et al.
Expert Review of Neurotherapeutics|December 10, 2020
Evaluating and managing severe headache in the emergency departmentMichelangelo Luciani, Andrea Negro, Valerio Spuntarelli, et al.
Expert Opinion on Biological Therapy|May 19, 2021
Eptinezumab for the treatment of migraineValerio Spuntarelli, Andrea Negro, Michelangelo Luciani, et al.
International Journal of Environmental Research and Public Health|January 27, 2021
Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective StudyEnrico Bentivegna, Michelangelo Luciani, Luca Arcari, et al.
Journal of Medical Virology|June 12, 2020
New IgM seroconversion and positive RT-PCR test after exposure to the virus in recovered COVID-19 patientEnrico Bentivegna, Alberto Sentimentale, Michelangelo Luciani, et al.
American Journal of Infection Control|October 8, 2020
Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infectionEnrico Bentivegna, Giuliano Alessio, Valerio Spuntarelli, et al.
Expert Review of Neurotherapeutics|November 5, 2021
Hormonal therapies in migraine management: current perspectives on patient selection and risk managementEnrico Bentivegna, Michelangelo Luciani, Francesco Scarso, et al.
Expert Opinion on Pharmacotherapy|July 19, 2022
Recently approved and emerging drug options for migraine prophylaxisEnrico Bentivegna, Michelangelo Luciani, Valeria Ferrari, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
SN Comprehensive Clinical Medicine|December 2, 2020
Headache as a Prognostic Factor for COVID-19. Time to Re-evaluatePaolo Martelletti, Enrico Bentivegna, Michelangelo Luciani, et al.
Expert Opinion on Drug Safety|March 22, 2021
Deprescribing in migrainePaolo Martelletti, Michelangelo Luciani, Valerio Spuntarelli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 1, 2022
Reply letter to: Correspondence on 'Coronavirus disease 2019 in patients with cardiovascular disease' (J Cardiovasc Med (Hagerstown). 2022 Jan 1;23(1):e42. doi: 10.2459/JCM.0000000000001276. PMID: 34874340.)Luca Arcari, Michelangelo Luciani, Luca Cacciotti, et al.
Expert Review of Neurotherapeutics|December 10, 2020
Evaluating and managing severe headache in the emergency departmentMichelangelo Luciani, Andrea Negro, Valerio Spuntarelli, et al.
Expert Opinion on Biological Therapy|May 19, 2021
Eptinezumab for the treatment of migraineValerio Spuntarelli, Andrea Negro, Michelangelo Luciani, et al.
International Journal of Environmental Research and Public Health|January 27, 2021
Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective StudyEnrico Bentivegna, Michelangelo Luciani, Luca Arcari, et al.
Journal of Medical Virology|June 12, 2020
New IgM seroconversion and positive RT-PCR test after exposure to the virus in recovered COVID-19 patientEnrico Bentivegna, Alberto Sentimentale, Michelangelo Luciani, et al.
American Journal of Infection Control|October 8, 2020
Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infectionEnrico Bentivegna, Giuliano Alessio, Valerio Spuntarelli, et al.
Expert Review of Neurotherapeutics|November 5, 2021
Hormonal therapies in migraine management: current perspectives on patient selection and risk managementEnrico Bentivegna, Michelangelo Luciani, Francesco Scarso, et al.
Expert Opinion on Pharmacotherapy|July 19, 2022
Recently approved and emerging drug options for migraine prophylaxisEnrico Bentivegna, Michelangelo Luciani, Valeria Ferrari, et al.
Pageof 3